ANPI Angiotech Pharmaceuticals - Common Shares (MM)

VANCOUVER, July 31 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the second quarter ended June 30, 2007. Thursday, August 2, 2007 at 11:00 AM (ET) (8:00 AM Pacific, 9:00 AM Mountain, 10:00 AM Central) Dial information is as follows: North America (toll-free): (866) 578-5788 International: (617) 213-8057 Enter passcode: 78719252 A live webcast will be available to all interested parties through Angiotech's website at http://www.angiotech.com/ under the Investors Relations section. A press release announcing Angiotech's financial results will be issued prior to the conference call at approximately 8:00 AM ET (5:00 AM Pacific, 6:00 AM Mountain, 7:00 AM Central). A replay archive of the conference call will be available until August 9, 2007. Replay archive information is as follows: North America: (888) 286-8010 International: (617) 801-6888 Enter passcode: 92205136 About Angiotech Pharmaceuticals Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ:ANPINASDAQ:TSXNASDAQ:ANP) please visit our website at http://www.angiotech.com/. CONTACT: Deirdre Neary, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056, ; Jodi Regts, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Deirdre Neary, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056, ; Jodi Regts, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930,

Copyright